|
2024
|
P/S
|
Pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders |
|
|
Invention
|
Benzodiazepine derivatives and antibody conjugates thereof.
The invention relates to novel cell-... |
|
|
Invention
|
Anti-folr1 immunoconjugate regimens.
Methods of administering immunoconjugates that bind to FOLR... |
|
|
Invention
|
Antibodies and assays for detection of folate receptor 1.
The invention generally relates to ant... |
|
|
Invention
|
Methods of preventing methionine oxidation in immunoconjugates.
The present invention generally ... |
|
|
Invention
|
Methods for the acylation of maytansinol.
Disclosed is a method of preparing an amino acid ester... |
|
2023
|
Invention
|
Therapeutic combinations comprising anti-cd123 antibody-drug conjugates and anti-cd47 antibodies.... |
|
|
Invention
|
Biparatopic fr-alpha antibodies and immunoconjugates.
The present disclosure provides biparatopi... |
|
|
Invention
|
Methods of preparing cell-binding agent-drug conjugates.
The present invention provides methods ... |
|
|
Invention
|
Methods for preparing maytansinoid derivatives with self-immolative peptide linkers. The inventio... |
|
|
Invention
|
Improved methods for preparing n-methyl alanine esters of maytansinol. Disclosed is a method of p... |
|
|
Invention
|
Folate receptor 1 antibodies and immunoconjugates and uses thereof.
Novel anti-cancer agents, in... |
|
|
Invention
|
Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders. ... |
|
|
Invention
|
Method of preparing indolinobenzodiazepine derivatives.
The invention provides novel methods for... |
|
|
Invention
|
Novel processes for preparing camptothecin derivatives. The invention provides novel methods for ... |
|
|
Invention
|
Preparation of maytansinoid antibody conjugates by a one-step process.
The invention provides a ... |
|
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharm... |
|
|
Invention
|
Epcam immunoconjugates and uses thereof. The disclosure generally relates to immunoconjugates com... |
|
|
Invention
|
Conjugates comprising cell-binding agents and cytotoxic agents.
The invention relates to novel c... |
|
|
Invention
|
Therapeutic combinations comprising anti-cd123 immunoconjugates.
Therapeutic combinations of imm... |
|
|
P/S
|
Business administration of patient pharmaceutical
reimbursement programs; business administratio... |
|
|
Invention
|
Methods for detection of folate receptor 1 in a patient sample.
The invention generally relates ... |
|
|
P/S
|
Charitable services, namely, patient assistance programs to
provide medical laboratory and analy... |
|
|
Invention
|
Methods of preparing cytotoxic benzodiazepine derivatives.
The invention provides novel methods ... |
|
2022
|
Invention
|
Selective sulfonation of benzodiazepine derivatives.
The invention relates to novel methods of p... |
|
|
Invention
|
Methods for formulating antibody drug conjugate compositions.
The present invention provides imp... |
|
|
Invention
|
Methods of preparing cytotoxic benzodiazepine derivatives.
The invention relates to novel method... |
|
|
P/S
|
Business administration of patient pharmaceutical reimbursement programs; business administration... |
|
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceutical
preparations for treatment of cancer; phar... |
|
|
Invention
|
Methods of treatment using anti-cd123 immunoconjugates.
Methods of administering immunoconjugate... |
|
|
Invention
|
Cytotoxic benzodiazepine derivatives.
The invention relates to novel benzodiazepine derivatives ... |
|
|
Invention
|
Conjugation methods.
This invention describes a method of conjugating a cell binding agent such ... |
|
|
Invention
|
Process for preparing purified drug conjugates.
The invention provides a process for preparing a... |
|
|
Invention
|
Improved methods for preparing cytotoxic benzodiazepine derivatives. The invention provides novel... |
|
|
P/S
|
Charitable services, namely, patient assistance programs to provide medical laboratory and analys... |
|
|
Invention
|
Novel processes for preparing camptothecin derivatives. Provided are methods for preparing campto... |
|
|
Invention
|
Methods of preparing cytotoxic benzodiazepine derivatives. The invention provides novel methods f... |
|
|
Invention
|
Biparatopic fr-alpha antibodies and immunoconjugates. The present disclosure provides biparatopic... |
|
|
Invention
|
Treatment of cancer in patients with soluble fr-alpha.
The present disclosure demonstrates that ... |
|
|
Invention
|
Diagnostic assays and kits for detection of folate receptor 1.
The invention generally relates t... |
|
|
Invention
|
Treatment of cancer in patients with soluble fr-alpha. The present disclosure demonstrates that t... |
|
|
P/S
|
Pharmaceutical products for human use, namely, pharmaceutical preparations for treatment of cance... |
|
|
P/S
|
House mark for pharmaceutical products for human use,
namely, pharmaceutical preparations for tr... |
|
|
Invention
|
Anti-folr1 immunoconjugate dosing regimens.
Methods of administering immunoconjugates that bind ... |
|
|
Invention
|
Anti-cd123 antibodies and conjugates and derivatives thereof. The present invention generally rel... |
|
|
Invention
|
Methods for increasing efficacy of immunoconjugates targeting adam9 for the treatment of cancer. ... |
|
|
Invention
|
Therapeutic combinations comprising anti-folr1 immunoconjugates.
Therapeutic combinations of imm... |
|
|
Invention
|
Methods for antibody drug conjugation, purification, and formulation.
Methods of producing, puri... |
|
2021
|
Invention
|
Method for increasing the efficacy of cancer therapy by administering an anti-folr1 immunoconjuga... |
|
|
P/S
|
House mark for pharmaceutical products for human use, namely, pharmaceutical preparations for tre... |
|
|
Invention
|
Methods for increasing efficacy of folr1 cancer therapy.
Methods to improve the success of cance... |
|
|
Invention
|
Cytotoxic benzodiazepine derivatives. The invention relates to novel benzodiazepine derivatives w... |
|
|
P/S
|
Pharmaceutical products for human use, none of the aforesaid being pharmaceutical preparations fo... |
|
|
P/S
|
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer, namel... |
|
2020
|
Invention
|
Cytotoxic bis-benzodiazepine derivatives and conjugates thereof with cell-binding agents for inhi... |
|
2018
|
P/S
|
House mark for pharmaceutical products for human use |
|
|
P/S
|
Pharmaceutical products for human use. |
|
|
P/S
|
Pharmaceuticals for human use. |
